Desprescribing antihypertensives in older people in primary care: subgroup analysis of the MINOR randomised clinical trial
- PMID: 39503798
- DOI: 10.1007/s11096-024-01805-y
Desprescribing antihypertensives in older people in primary care: subgroup analysis of the MINOR randomised clinical trial
Abstract
Background: Polypharmacy is often required for older adults with hypertension, and excessive treatment is associated with a high risk of adverse reactions, including hypotension.
Aim: To evaluate the deprescribing of antihypertensive medications guided by pharmacists using home blood pressure monitoring in older adults with hypotension.
Method: A subgroup of older adults with signs or symptoms of hypotension, included in the MINOR clinical trial, was analysed. In the MINOR procedures, each patient was provided with a device to conduct blood pressure measurement at home for 1 week, following which a report was generated and shared with pharmacists (intervention group) or family physicians (control group). In the intervention group, a pharmacist suggested optimising pharmacotherapy; meanwhile, in the control group, a family physician alone determined the necessary treatment adjustments. Differences in mean blood pressure, the patients with symptoms/signs of hypotension, and the antihypertensive medication deprescribing between both groups were analysed.
Results: Seventy-two patients were evaluated (35, control group; 37, intervention group). The intervention group showed a significant reduction in medication prescriptions (- 28.6%; P < 0.001), especially beta-blockers (- 74.2%), loop diuretics (- 83.3%), and aldosterone antagonists (- 80%). The mean office blood pressure in the intervention group increased (14.1 mmHg systolic and 6.9 mmHg diastolic), remaining below the target range (140/90 mmHg). The intervention group showed a significantly reduction in hypotensive symptoms than the control group (64.9% vs. 20%) (P < 0.001).
Conclusion: The data highlight an important role for pharmacists in optimizing hypertension management in older people. Deprescribing antihypertensives can limit symptomatic hypotension.
Trial registration: Registered on ClinicalTrials.gov under number NCT04861727.
Keywords: Arterial hypertension; Deprescription; Hypotension; Primary health care.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflict of interest.
References
-
- Barroso WKS, Rodrigues CIS, Bortolotto LA, et al. Brazilian guidelines for hypertension, 2020. Arq Bras Cardiol. 2021;116:516–658. https://doi.org/10.36660/abc.20201238 . - DOI - PubMed - PMC
-
- Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. https://doi.org/10.1016/S0140-6736(12)60240-2 . - DOI - PubMed
-
- Marques AP, Szwarcwald CL, Pires DC, et al. Factors associated with arterial hypertension: a systematic review. Cien Saúde Colet. 2020;25:2271–82. https://doi.org/10.1590/1413-81232020256.26972018 . - DOI - PubMed
-
- Bai I, Isenor JE, Reeve E, et al. The behavioural change wheel was used to link published deprescribing strategies to identify local primary healthcare needs. Res Soc Adm Pharm. 2022;18:3350–7. https://doi.org/10.1016/j.sapharm.2021.12.001 . - DOI
-
- Brazil MoH. [Elderly Health: Thematic Bulletin 2022]. Brasília: Ministry of Health. https://bvsms.saude.gov.br/bvs/boletim_tematico/saude_idoso_outubro_2022... . Accessed 10 Aug 2023.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical